HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PEGBIO CO-B

5.620

+0.0400.72%

Volume:5.84M

Turnover:32.89M

Market Cap:2.20B

PE:-8.75

High:5.845

Open:5.630

Low:5.450

Close:5.580

52wk High:77.000

52wk Low:4.940

Shares:391.00M

HK Float Shares:386.00M

Volume Ratio:0.76

T/O Rate:1.51%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.642

ROE:-125.57%

ROA:-44.55%

PB:7.05

PE(LYR):-8.75

PS:-164.33

Loading ...

Overview Company News Filings

Movement Alert｜PEGBIO CO-B Declines 8.12% in Regular Trading, Trading at 6.36 HKD

PegBio's Diabetes Drug Completes First Batch of Prescriptions

MT Newswires Live

PegBio’s Paidakang® Enters Clinical Use Nationwide, Unlocks HK$49.00 Million Second Royalty from Tenry Pharmaceutical

Bulletin Express

PEGBIO CO-B Announces First Commercial Prescriptions for Paidakang and Fulfillment of Second Milestone Payment

Movement Alert｜PegBio Rises 8.04% in Regular Trading, Three-Party Strategic Cooperation Accelerates Paidakang Commercialization Expectations

PEGBIO CO-B Surges Over 5% on Strategic Collaboration to Accelerate Commercialization of Pai Da Kang

Alibaba Health Inks Strategic Tie-up with Tenry, Pegbio to Launch Glp-1ra Drug

Alibaba Health Says it Signed Strategic Cooperation with Tenry Pharmaceutical and Pegbio on Glp-1ra Drug

THOMSON REUTERS

PegBio, Tengrui Pharma, and Ali Health Forge Strategic Alliance to Accelerate Commercialization and Market Expansion of Patacon

Movement Alert｜PegBio Intraday Decline 8.04%, Rani Therapeutics Catalyst Fading Amid Broad Biotech Sector Selloff

Movement Alert｜PegBio Pharma-B Rises 8.78% in Regular Trading, Technical Rebound After Prior Session Pullback With Rani Collaboration Catalyst Intact

Movement Alert｜PegBio Intraday Decline 8.11%, Profit-Taking Emerges After Rani Therapeutics Partnership Rally

Movement Alert｜PegBio Rises 8.42% in Regular Trading, Rani Therapeutics Oral Delivery Partnership Continues to Fuel Market Enthusiasm

Movement Alert｜PegBio Rises 38.16% in Regular Trading, Partners with Rani Therapeutics to Advance Oral Delivery of Metabolic Assets

PEGBIO Shares Surge Over 21% on Oral Delivery Collaboration with Rani Therapeutics

PegBio Partners with Rani: Oral Delivery Platform Opens Global Revaluation Path for Next-Generation Metabolic Assets

Pegbio Co - Enters Mou with Nasdaq-listed Rani Therapeutics

THOMSON REUTERS

Pegbio Co - Collaboration to Advance Oral Delivery of Multiple Metabolic Assets

THOMSON REUTERS

Rani Therapeutics Partners with Pegbio to Develop Oral Obesity Drug Candidates

PEGBIO Shares Surge on Positive Progress for Diabetes Drug in National Reimbursement Review

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/02565/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"PEGBIO CO-B","latestPrice":5.62,"timestamp":1789027724005,"preClose":5.58,"halted":0,"volume":5840950,"delay":0,"changeRate":0.007168458781362013,"floatShares":386000000,"shares":391000000,"eps":-0.6424394030880705,"marketStatus":"Not Yet Opened","change":0.04,"latestTime":"09-10 16:08:44","open":5.63,"high":5.845,"low":5.45,"amount":32892209,"amplitude":0.070789,"askPrice":5.62,"askSize":13450,"bidPrice":5.615,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":-0.9970566090195495,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":5.58,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.755024,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":386000000,"roa":"-44.55%","roe":"-125.57%","lyrEps":-0.642439,"volumeRatio":0.755024,"shares":391000000,"dividePrice":0,"high":5.845,"amplitude":0.070789,"preClose":5.58,"low":5.45,"week52Low":4.94,"pbRate":"7.05","psRate":"-164.33","week52High":77,"institutionHeld":0,"latestPrice":5.62,"committee":-0.147122,"eps":-0.6424394030880705,"divideRate":0,"volume":5840950,"delay":0,"ttmEps":-0.9970566090195495,"open":5.63,"prevYearClose":69,"prevWeekClose":5.735,"prevMonthClose":5.495,"prevQuarterClose":5.33,"fiveDayClose":5.7,"twentyDayClose":6.455,"sixtyDayClose":6.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787621400000,"name":null,"time":"","dateTimestamp":1787587200000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"02565","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2026-09-09","current":-5.589593,"percent":0.993528,"low":-87.782868,"twenty":-72.567571,"median":-50.277222,"eighty":-11.249462,"high":-5.557418,"avg":-42.712482,"sd":28.499314,"marketCap":2182290748},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441},{"date":"2025-11-21","current":-72.852961,"twenty":-61.301982,"median":-40.866122,"eighty":-12.943343,"marketCap":17657144441},{"date":"2025-11-28","current":-82.344376,"twenty":-62.346137,"median":-42.423494,"eighty":-13.014482,"marketCap":20030041323},{"date":"2025-12-05","current":-72.063717,"twenty":-63.355663,"median":-45.122001,"eighty":-13.104279,"marketCap":17559436923},{"date":"2025-12-12","current":-74.217813,"twenty":-64.460997,"median":-48.969529,"eighty":-13.233973,"marketCap":18117765601},{"date":"2025-12-19","current":-71.875632,"twenty":-65.413889,"median":-52.055133,"eighty":-13.542645,"marketCap":17587353357},{"date":"2025-12-24","current":-73.927127,"twenty":-69.382811,"median":-55.337969,"eighty":-13.579586,"marketCap":18145682035},{"date":"2026-01-02","current":-79.895405,"twenty":-70.540926,"median":-57.311117,"eighty":-13.748078,"marketCap":19687798475},{"date":"2026-01-09","current":-85.854057,"twenty":-72.056904,"median":-58.941314,"eighty":-13.964201,"marketCap":21208805289},{"date":"2026-01-16","current":-80.413876,"twenty":-72.839385,"median":-59.401661,"eighty":-14.164153,"marketCap":19929453763},{"date":"2026-01-23","current":-77.735339,"twenty":-73.262106,"median":-59.808211,"eighty":-14.656731,"marketCap":19247132950},{"date":"2026-01-30","current":-73.838267,"twenty":-73.550435,"median":-60.0941,"eighty":-15.472199,"marketCap":18365801899},{"date":"2026-02-06","current":-69.490034,"twenty":-73.32273,"median":-60.154331,"eighty":-16.538679,"marketCap":17328105662},{"date":"2026-02-13","current":-71.473742,"twenty":-73.562339,"median":-60.192909,"eighty":-17.006135,"marketCap":17925136373},{"date":"2026-02-20","current":-71.065981,"twenty":-73.716985,"median":-60.392128,"eighty":-17.056006,"marketCap":17797201221},{"date":"2026-02-27","current":-72.540901,"twenty":-73.438012,"median":-60.796223,"eighty":-17.950543,"marketCap":18365801899},{"date":"2026-03-06","current":-68.036226,"twenty":-73.352041,"median":-61.160082,"eighty":-18.384598,"marketCap":17086450373},{"date":"2026-03-13","current":-60.794114,"twenty":-73.299371,"median":-60.919795,"eighty":-18.597951,"marketCap":15338003289},{"date":"2026-03-20","current":-67.303035,"twenty":-73.275932,"median":-61.206433,"eighty":-18.84686,"marketCap":16915870170},{"date":"2026-03-27","current":-68.867925,"twenty":-73.269478,"median":-61.274827,"eighty":-18.985169,"marketCap":16247764373},{"date":"2026-04-02","current":-85.055535,"twenty":-73.278872,"median":-61.433108,"eighty":-19.026504,"marketCap":20163286400},{"date":"2026-04-10","current":-78.454069,"twenty":-73.369897,"median":-61.662876,"eighty":-19.045802,"marketCap":18741784705},{"date":"2026-04-17","current":-76.94604,"twenty":-73.948705,"median":-62.45145,"eighty":-19.079188,"marketCap":18389252284},{"date":"2026-04-24","current":-60.4786,"twenty":-73.948705,"median":-62.528681,"eighty":-19.126247,"marketCap":14454535592},{"date":"2026-05-15","current":-17.642518,"twenty":-73.927127,"median":-62.346137,"eighty":-19.115451,"marketCap":4376314243},{"date":"2026-05-22","current":-20.448357,"twenty":-73.838267,"median":-61.433108,"eighty":-19.16943,"marketCap":5060724424},{"date":"2026-05-29","current":-13.590249,"twenty":-73.716985,"median":-61.274827,"eighty":-19.064042,"marketCap":3375119921},{"date":"2026-06-05","current":-12.579887,"twenty":-73.438012,"median":-61.206433,"eighty":-18.597951,"marketCap":3128732256},{"date":"2026-06-12","current":-11.565594,"twenty":-73.352041,"median":-60.919795,"eighty":-17.056006,"marketCap":2874522760},{"date":"2026-06-18","current":-9.622776,"twenty":-73.31105,"median":-60.791238,"eighty":-14.753422,"marketCap":2397391091},{"date":"2026-06-26","current":-7.824338,"twenty":-73.278872,"median":-60.512398,"eighty":-13.899973,"marketCap":1939813998},{"date":"2026-07-03","current":-8.984958,"twenty":-73.271235,"median":-60.431019,"eighty":-13.561687,"marketCap":2229221732},{"date":"2026-07-10","current":-11.252888,"twenty":-73.25947,"median":-60.210807,"eighty":-13.050401,"marketCap":2788482623},{"date":"2026-07-17","current":-10.458113,"twenty":-73.235067,"median":-60.159469,"eighty":-12.830773,"marketCap":2600758687},{"date":"2026-07-24","current":-10.046967,"twenty":-73.215248,"median":-60.107782,"eighty":-12.739192,"marketCap":2499074889},{"date":"2026-07-31","current":-8.411523,"twenty":-73.183292,"median":-59.862622,"eighty":-12.522041,"marketCap":2096250611},{"date":"2026-08-07","current":-10.298244,"twenty":-73.061453,"median":-59.675079,"eighty":-12.306772,"marketCap":2571426822},{"date":"2026-08-14","current":-9.745542,"twenty":-72.966779,"median":-59.367669,"eighty":-11.991332,"marketCap":2436500244},{"date":"2026-08-21","current":-9.169953,"twenty":-72.846173,"median":-58.454271,"eighty":-11.546541,"marketCap":2297662750},{"date":"2026-08-28","current":-5.766342,"twenty":-72.790068,"median":-56.898206,"eighty":-11.368021,"marketCap":2225310817},{"date":"2026-09-04","current":-5.809614,"twenty":-72.647581,"median":-53.43223,"eighty":-11.296065,"marketCap":2242909936},{"date":"2026-09-09","current":-5.643565,"twenty":-72.567571,"median":-50.277222,"eighty":-11.249462,"marketCap":2182290748}],"updateTime":1789026272826},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1198005740","title":"Movement Alert｜PEGBIO CO-B Declines 8.12% in Regular Trading, Trading at 6.36 HKD","url":"https://stock-news.laohu8.com/highlight/detail?id=1198005740","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198005740?lang=en_us&edition=fundamental","pubTime":"2026-07-24 14:01","pubTimestamp":1784872872,"startTime":"0","endTime":"0","summary":"On July 24, PEGBIO CO-B declined 8.12% in regular trading, trading at 6.36 HKD/share, with turnover of HK$44.80 million.Within the Biotechnology sector where PEGBIO CO-B belongs, the sector showed...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653763372","title":"PegBio's Diabetes Drug Completes First Batch of Prescriptions","url":"https://stock-news.laohu8.com/highlight/detail?id=2653763372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653763372?lang=en_us&edition=fundamental","pubTime":"2026-07-22 21:14","pubTimestamp":1784726047,"startTime":"0","endTime":"0","summary":"PegBio  said the first batch of commercial prescriptions of Paidakang has been issued at multiple medical institutions, according to a Wednesday Hong Kong bourse filing.Ji Linong and Zhou Zhiguang issued the first respective prescriptions at Peking University People's Hospital and Second Xiangya Hospital of Central South University.Ji and Zhou were the leading experts of a phase III clinical study of Paidakang, which is used for the treatment of type 2 diabetes in adults.Following the prescriptions, Tenry Pharmaceutical, which had entered into a commercialization collaboration agreement with the company, is due to satisfy a second royalty payment.Tenry Pharmaceutical has confirmed it will pay around HK$49 million in royalty to the biopharmaceutical company under the contract.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193880564","title":"PegBio’s Paidakang® Enters Clinical Use Nationwide, Unlocks HK$49.00 Million Second Royalty from Tenry Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=1193880564","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193880564?lang=en_us&edition=fundamental","pubTime":"2026-07-22 18:21","pubTimestamp":1784715690,"startTime":"0","endTime":"0","summary":"PegBio Co., Ltd. (PegBio) announced that, as of 22 July 2026, the first batch of commercial prescriptions for Paidakang®—its once-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) for adult...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182451049","title":"PEGBIO CO-B Announces First Commercial Prescriptions for Paidakang and Fulfillment of Second Milestone Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=1182451049","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182451049?lang=en_us&edition=fundamental","pubTime":"2026-07-22 18:10","pubTimestamp":1784715039,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) has announced that, as of July 22, 2026, the first commercial prescriptions for Paidakang® have been issued across multiple medical institutions in China, including Peking...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161726","BK4588","XBI","02565","BK4585","BK1161","BK4581","399441"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193644409","title":"Movement Alert｜PegBio Rises 8.04% in Regular Trading, Three-Party Strategic Cooperation Accelerates Paidakang Commercialization Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1193644409","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193644409?lang=en_us&edition=fundamental","pubTime":"2026-07-21 14:59","pubTimestamp":1784617161,"startTime":"0","endTime":"0","summary":"On July 21, PegBio (02565.HK) rose 8.04% in regular trading, reaching HK$7.39, with turnover of HK$148 million.On the news front, on July 17, PegBio, Shanghai Tenry Pharmaceutical, and Ali Health...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149654436","title":"PEGBIO CO-B Surges Over 5% on Strategic Collaboration to Accelerate Commercialization of Pai Da Kang","url":"https://stock-news.laohu8.com/highlight/detail?id=1149654436","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149654436?lang=en_us&edition=fundamental","pubTime":"2026-07-20 11:54","pubTimestamp":1784519664,"startTime":"0","endTime":"0","summary":"Shares of PEGBIO CO-B (02565) rose more than 5%. At the time of writing, the stock was up 5.41% to HK$7.01, with a turnover of HK$132 million.On the news front, on July 17, PEGBIO CO-B, Shanghai...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399441","BK4588","BK4581","BK1161","161726","02565","BK4585","KCAI","XBI","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652628894","title":"Alibaba Health Inks Strategic Tie-up with Tenry, Pegbio to Launch Glp-1ra Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2652628894","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652628894?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:57","pubTimestamp":1784289464,"startTime":"0","endTime":"0","summary":"BRIEF-Alibaba Health Inks Strategic Tie-Up With Tenry, PegBio To Launch GLP-1RA DrugJuly 17 (Reuters)-Alibaba Health Information Technology Ltd0241.HK:SAYS IT SIGNED STRATEGIC COOPERATION WITH TENRY PHARMACEUTICAL AND PEGBIO CO LTD TO LAUNCH GLP-1RA DRUGSource textFurther company coverage:0241.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nL4N43J0WI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","BK1189","BK1589","BK1615","00241","BK1161","BK1591","BK1247","02565","BK1502","BK1571","BK1501","BK1610","HK0000165453.HKD","BK1142","BK1515","BK1584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652288398","title":"Alibaba Health Says it Signed Strategic Cooperation with Tenry Pharmaceutical and Pegbio on Glp-1ra Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2652288398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652288398?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:57","pubTimestamp":1784289464,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nL4N43J0WI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1142","BK1161","BK1247","BK1615","BK1617","HK0000165453.HKD","BK1584","02565","BK1515","BK1589","BK1502","BK1189","BK1591","00241","BK1610","BK1501","BK1571"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133815765","title":"PegBio, Tengrui Pharma, and Ali Health Forge Strategic Alliance to Accelerate Commercialization and Market Expansion of Patacon","url":"https://stock-news.laohu8.com/highlight/detail?id=1133815765","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133815765?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:05","pubTimestamp":1784282751,"startTime":"0","endTime":"0","summary":"On July 17, PegBio Co-B (02565), Shanghai Tengrui Pharmaceutical Co., Ltd., and Ali Health (00241) formally signed a strategic cooperation agreement in Hangzhou.The three parties will leverage their...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","HK0000165453.HKD","BK1142","BK1161","BK1247","BK1615","01477","02565","BK1574","BK1571","BK1191","BK1617","BK1501","BK1610","BK1502","BK1591","BK1189","BK1589","BK1584","00241"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148765165","title":"Movement Alert｜PegBio Intraday Decline 8.04%, Rani Therapeutics Catalyst Fading Amid Broad Biotech Sector Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=1148765165","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148765165?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:17","pubTimestamp":1784254641,"startTime":"0","endTime":"0","summary":"On July 17, PegBio (02565.HK) fell 8.04% in regular trading, trading at HK$6.27/share, with turnover of HK$47.87 million.The decline reflects continued profit-taking as the catalytic effect of the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116906710","title":"Movement Alert｜PegBio Pharma-B Rises 8.78% in Regular Trading, Technical Rebound After Prior Session Pullback With Rani Collaboration Catalyst Intact","url":"https://stock-news.laohu8.com/highlight/detail?id=1116906710","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116906710?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:47","pubTimestamp":1784080026,"startTime":"0","endTime":"0","summary":"On July 15, PegBio Pharma-B rose 8.78% in regular trading, trading at HK$6.64/share, with turnover of HK$75.66 million. The rebound follows the prior session's approximately 8% decline driven by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164934874","title":"Movement Alert｜PegBio Intraday Decline 8.11%, Profit-Taking Emerges After Rani Therapeutics Partnership Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1164934874","media":"Market Focus","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164934874?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:29","pubTimestamp":1784006953,"startTime":"0","endTime":"0","summary":"On July 14, PegBio (02565.HK) declined 8.11% in regular trading, trading at HKD 5.91/share, with turnover of HKD 121 million. The pullback follows a sharp rally driven by the company's memorandum of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184828201","title":"Movement Alert｜PegBio Rises 8.42% in Regular Trading, Rani Therapeutics Oral Delivery Partnership Continues to Fuel Market Enthusiasm","url":"https://stock-news.laohu8.com/highlight/detail?id=1184828201","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184828201?lang=en_us&edition=fundamental","pubTime":"2026-07-13 09:46","pubTimestamp":1783907175,"startTime":"0","endTime":"0","summary":"On July 13, PegBio (02565.HK) rose 8.42% in regular trading, trading at HKD 7.29/share, with turnover of HKD 108 million, extending the strong rally momentum from the previous Friday.The sustained...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147750283","title":"Movement Alert｜PegBio Rises 38.16% in Regular Trading, Partners with Rani Therapeutics to Advance Oral Delivery of Metabolic Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=1147750283","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147750283?lang=en_us&edition=fundamental","pubTime":"2026-07-10 11:09","pubTimestamp":1783652958,"startTime":"0","endTime":"0","summary":"On July 10, PegBio (02565.HK) surged 38.16% in regular trading, reaching HKD 7.64 per share, with turnover of HKD 530 million. The stock opened sharply higher and continued to strengthen throughout...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136807453","title":"PEGBIO Shares Surge Over 21% on Oral Delivery Collaboration with Rani Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=1136807453","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136807453?lang=en_us&edition=fundamental","pubTime":"2026-07-10 09:40","pubTimestamp":1783647629,"startTime":"0","endTime":"0","summary":"PEGBIO CO-B (ASX: 02565) shares experienced a significant surge of over 21% in today's trading session. At the time of writing, the stock was up 21.88% to HK$6.77, with a trading volume of HK$60.81...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4581","161726","BK1161","399441","KCAI","BK4585","XBI","BK4588","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155519004","title":"PegBio Partners with Rani: Oral Delivery Platform Opens Global Revaluation Path for Next-Generation Metabolic Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=1155519004","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155519004?lang=en_us&edition=fundamental","pubTime":"2026-07-10 08:50","pubTimestamp":1783644628,"startTime":"0","endTime":"0","summary":"Following the commercialization of its core product Vipenatide, PegBio is adding new product forms and overseas development pathways for its next-generation metabolic innovation pipeline.It has been...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650704749","title":"Pegbio Co - Enters Mou with Nasdaq-listed Rani Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2650704749","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650704749?lang=en_us&edition=fundamental","pubTime":"2026-07-10 08:00","pubTimestamp":1783641649,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43B0M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650420970","title":"Pegbio Co - Collaboration to Advance Oral Delivery of Multiple Metabolic Assets","url":"https://stock-news.laohu8.com/highlight/detail?id=2650420970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650420970?lang=en_us&edition=fundamental","pubTime":"2026-07-10 08:00","pubTimestamp":1783641649,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43B0M6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02565","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650974640","title":"Rani Therapeutics Partners with Pegbio to Develop Oral Obesity Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2650974640","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650974640?lang=en_us&edition=fundamental","pubTime":"2026-07-10 04:11","pubTimestamp":1783627893,"startTime":"0","endTime":"0","summary":"Rani Therapeutics partners with PegBio to develop oral obesity drug candidatesRani Therapeutics entered an R&D collaboration with PegBio to develop oral RaniPill formulations for multiple obesity and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260709:nNDL2Yk8gq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4007","BK4539","RANI","02565"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116321689","title":"PEGBIO Shares Surge on Positive Progress for Diabetes Drug in National Reimbursement Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1116321689","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116321689?lang=en_us&edition=fundamental","pubTime":"2026-07-02 13:46","pubTimestamp":1782971187,"startTime":"0","endTime":"0","summary":" Shares of PEGBIO CO-B (ASX: 02565) rose more than 5%, trading up 4.13% at HK$5.55 by the latest update, with a turnover of HK$39.02 million. Key Development The company recently announced that its...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4581","02565","161726","399441","XBI","VXUS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":117,"code":"91000000","status":"200"}]}}